doi: 10.1001/jama.2022.0078 39 Chang-ChenKJMullurRBernal-MizrachiE
Victoza is a once-daily GLP-1 RA therapy for patients with type 2 diabetes Indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
A follow-up analysis found that liraglutide slowed down stomach emptying in 57% of obesity patients, but tachyphylaxis helped 19 out of 39 affected patients return to normal within 16 weeks [28]
Para los pacientes, esto significa que el tratamiento del hgado graso ya no se limita a recomendaciones generales, sino que comienza a apoyarse en opciones teraputicas con bases cientficas slidas
Barboi OB, Chirila I, Ciortescu I, Anton C, Drug VL
Common examples include: Ozempic: FDA-approved for type 2 diabetes but sometimes prescribed off-label for weight loss
